Screener

Depreciation

Name: Ligand Pharmaceuticals Depreciation by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Ligand Pharmaceuticals·Business Segments·1 segment·Rolls up to D&A

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Business Segments	$513K	$264K	$172K	$42K	$119K	$118K
Total	$8.77M	$8.52M	$8.27M	$8.21M	$8.22M	$8.22M

Business SegmentsView metric